MCKESSON CORP SG&A Expense 2012-2026 | MCK
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is MCKESSON CORP's current sg&a expense?
MCKESSON CORP (MCK) annual sg&a expense for 2026 was $8.10B, a 4.83% decline from 2025. MCKESSON CORP sg&a expense for the quarter ending March 31, 2026 was $1.80B.
What was MCKESSON CORP's sg&a expense in 2025?
MCKESSON CORP annual sg&a expense for 2025 was $8.51B, a 1.73% decline from 2024.
What was MCKESSON CORP's sg&a expense in 2024?
MCKESSON CORP annual sg&a expense for 2024 was $8.66B, a 11.33% increase from 2023.
What is MCKESSON CORP's 5-year sg&a expense CAGR?
MCKESSON CORP sg&a expense grew at a compound annual growth rate (CAGR) of 1.76% from FY2021 to FY2026, going from $8.85B to $8.10B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-1.8%
FY2021
$8.85B
→
FY2026
$8.10B
121314151617181920212223242526
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2026 | $8.10B | -4.8% | 10-K |
| FY2025 | $8.51B | -1.7% | 10-K |
| FY2024 | $8.66B | +11.3% | 10-K |
| FY2023 | $7.78B | -26.2% | 10-K |
| FY2022 | $10.54B | +19.1% | 10-K |
| FY2021 | $8.85B | -3.6% | 10-K |
| FY2020 | $9.18B | +8.8% | 10-K |
| FY2019 | $8.44B | +3.7% | 10-K |
| FY2018 | $8.14B | +9.3% | 10-K |
| FY2017 | $7.45B | +0.9% | 10-K |
| FY2016 | $7.38B | -6.6% | 10-K |
| FY2015 | $7.90B | +46.6% | 10-K |
| FY2014 | $5.39B | +31.1% | 10-K |
| FY2013 | $4.11B | +10.3% | 10-K |
| FY2012 | $3.73B | - | 10-K |
Company: MCKESSON CORPTicker: MCKSector: HealthcareIndustry: Wholesale-Drugs, Proprietaries & Druggists' SundriesView company profile →